Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00363090
Brief Title: Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma

First Submitted : August 10, 2006
First Submitted that Met QC Criteria : August 10, 2006
First Posted : August 15, 2006 (Estimate)

Last Update Submitted that Met QC Criteria : September 19, 2013
Last Update Posted : September 20, 2013 (Estimate)